Sarang Rastogi

Sarang Rastogi has extensive experience in the pharmaceutical and healthcare industry. Most recently, they served as the Director and Global Clinical Development Lead at REGENXBIO Inc., where they led the development of gene therapy programs for Homozygous Familial Hypercholesterolemia and late infantile neuronal ceroid lipofuscinosis type 2. Prior to that, Sarang worked at AstraZeneca as the Global Medical Affairs Leader for Respiratory Biologics, overseeing the medical strategy for FasenraTM and leading the development of integrated medical affairs plans. Sarang also served as the Global Medical Affairs Leader for Neuroscience at AstraZeneca, responsible for the global launch readiness of MOVANTIKTM. Sarang's earlier experience includes roles at Sanofi, Express Scripts, V-Clinical Research Inc, Progenics Pharmaceuticals, TKL Research, and CVS Health, where they gained expertise in health economics, strategic planning, clinical trial management, and pharmacy operations.

Sarang Rastogi attended Brown University for an unknown period of time. After that, they attended Rutgers University, where they obtained a Doctor of Pharmacy (PharmD) degree. No specific field of study is provided.